That is the title of the podcast episode I was on for AJMC’s Managed Care Cast. We discuss my recently published paper on insurance value in Duchenne’s Muscular Dystrophy (DMD). To learn more about research in DMD, check out AJMC’s DMD compendia page. The full podcast is below.
Similar Posts
Judge approves 23andMe sale amid privacy dispute
A bankruptcy judge has approved the sale of 23andMe to the nonprofit TTAM Research Institute, owned…
Regard secures $61M to research LLMs, expand clinical insights platform
Los Angeles-based clinical decision software company Regard announced it closed a $61 million Series B round…
Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities
Morgan Health made a $25 million investment in Merative, a data, analytics and technology provider, the…
The Troubling Link Between Pesticides & Parkinson’s Disease Risk
Beauty & Health Editor Hannah Frye is the Beauty & Health Editor at mindbodygreen. She has…
Sleep Loss Is Associated With These Major Skin Concerns
Sleep is a pillar of health—a vital sign, the gateway to cellular regeneration, the foundation of…
ŌURA Unveils 2 New Features for Heart Health – MedCity News
ŌURA, a wearable device company, announced Friday that it has two new heart health features that…